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Excessive consumption of fructose in the Western diet has been associated
with metabolic disorders such as type 2 diabetes and obesity. Altered expres-
sion and activity of the fructose uniporter GLUT5, a member of the family of
GLUT transporters that facilitate the diffusion of monosaccharides across
membranes, has been linked to such disorders. Using Saccharomyces cerivi-
siae as an expression host, and fluorescence-based methods, we identified
mammalian GLUT5 orthologues that are suitable for biochemical and struc-
tural studies. Here, we present a crystal structure of GLUT5 from Bos Taurus
(bovine) in an inward-facing conformation, refined against data extending to
~ 3.1 A˚ resolution. Like GLUT1, GLUT5 shows the typical Major Facilitator
Superfamily (MFS) fold, which consists of two 6-TM bundles, and four
additional helices that form a soluble domain on the cytoplasmic side of
the membrane. The substrate-binding site is highly similar to that observed
in the recent crystal structure of human GLUT1, and to those of other
GLUT isoforms based on amino acid sequence. However, there are notable
differences. In particular, the substrate-binding site of GLUT5 is larger,
because the equivalent of a tryptophan residue lining the cavity that contains
the substrate-binding site in GLUT1 is an alanine in GLUT5. Furthermore,
we have identified a single point mutation that switches the substrate prefer-
ence of GLUT5 from D-fructose to D-glucose. Overall, our structural and
biochemical data provide novel insights into the structure and substrate spec-
ificity of GLUT5, a member of the family of the medically relevant GLUT
transporters.
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LmrP, a Major Facilitator Superfamily (MFS) multidrug transporter from
Lactococcus lactis, acts as a secondary antiporter, catalysing the extrusion
of a spectrum of hydrophobic drugs by dissipating a proton gradient. It has
evolved to bind and export structurally diverse cytotoxic substances from
within the membrane, in contrast to the majority of MFS transporters special-
ized in the transport of a single soluble substrate, captured from the aqueous
medium. Its transport mechanism could thus differ from the alternating access
model of the lactose permease, the actual paradigm for all MFS transporters.
Recently, we have shown that the protonation of conserved acidic residues is
the driving force of the conformational transition, and that substrate binding
initiates the cycle by catalysing proton passage (Masureel, Martens et al.
2014). While this analysis was performed on detergent solubilized protein,
we now aim to investigate the role of the lipid bilayer in the conformational
cycle. For this purpose, we performed Double Electron Electron Resonance
(DEER) distance measurements on a library of labeled double-cysteine mu-
tants monitoring both sides of the transporter. Spin labeled mutants were re-
constituted in nanodiscs and the distance changes monitored upon changes in
the pH or addition of substrate(s). We found that the pH-dependent equilib-
rium between the inside-open and outside-open conformations is strongly
shifted in nanodiscs compared to detergent, suggesting that the pKa of the
acidic residues is modified by the lipids. By combining specific lipidic
compositions and mutagenesis, we are investigating whether such change in
the dynamics are the results of direct phospholipid-protein interaction. Spe-
cific structural effects of given lipids are observed: small amounts of cardio-
lipin allow the conformational transition to occur at physiological pH. These
findings could shed light on the mechanism of MFS multidrug transporters in
general.136-Plat
Thermodynamic Features of IIAGlc Inhibition of Sugar Symporters
Hariharan Parmeswaran1, Balasubramaniam Dhandayuthapani2,
Alan Peterkofsky3, Ronald H. Kaback2, Lan Guan1.
1Cell Physiology & Molecular Biophysics, Center for Membrane Protein
Research, Texas Tech University Health Sciences Center, Lubbock, TX,
USA, 2Department of Physiology, University of California, Los Angeles, CA,
USA, 3Cell Biology and Physiology Center, National Heart, Lung and Blood
Institute, National Institutes of Health, Bethesda, MA, USA.
Carbohydrate uptake in certain bacteria is under the regulation of the phospho-
transfer protein IIAGlc. IIAGlc regulates the expression and activity of various
inducible transporters, including the Naþ-coupled melibiose permease (MelB)
andHþ-lactose permease (LacY).We characterized the thermodynamic features
of IIAGlc binding to both the permeases by applying chemical cross-link and
isothermal titration calorimetry. Here, we show that IIAGlc directly binds to
MelB or LacY in the absence or presence of melibiose, a sugar substrate for
both permeases. The protein-protein interaction in both cases exhibits dissocia-
tion constant between 3-10 mMat a stoichiometry of one. Strikingly, the thermo-
dynamic strategy for the binding is different. The binding to MelB, which is
crystallized in an outside-open conformation, is driven by enthalpy with
compensation of entropy; the binding to LacY, which is captured in an inside-
open conformation, is driven by entropy with compensation of enthalpy; how-
ever, the binding in both cases restrains the conformational entropy of the
permease. Consistently, we show that IIAGlc-bound MelB or LacY exhibits a
largely decreased affinity for sugar substrate. The data allow us to conclude
that IIAGlc regulates activity of MelB and LacY via restraining conformational
dynamics and an induced-fit process. In all cases studied, IIAGlc blocks inducer
entry into the cells thus preferentially favoring constitutive glucose uptake.
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Accurately determining stoichiometry is a vital step in the mechanistic charac-
terization of secondary active transporters, but has been difficult for many bac-
terial transporters. To address this problem we have developed a newmethod to
determine stoichiometry for electrogenic secondary transporters by measuring
the reversal potential, the voltage at which there is no net flux of ions or sub-
strate. Reversal potentials have been routinely measured for mammalian chan-
nels and transporters which are amenable to heterologous expression and
electrophysiological characterization. However, such measurements are much
more difficult for bacterial proteins, for which electrophysiology is not appli-
cable. A recent flood of X-ray structures of bacterial transport proteins, with
or without their coupling ions and substrates, and the accompanying efforts
to understand their mechanisms using experimental and computational ap-
proaches increases the urgency of obtaining accurate transport stoichiometries.
Our new method should be applicable to any electrogenic secondary trans-
porter, as it is based on the measurement of radioactive substrate flux. We pre-
load proteoliposomes containing purified reconstituted transporter with a set
amount of coupling ion and radiolabeled substrate, incubate the vesicles in
an external buffer also containing labeled substrate and coupling ion, then
set the transmembrane voltage using Kþ/valinomycin. With labeled substrate
at known concentrations, we can follow both substrate influx and efflux. By
making measurements at different voltages inducing both influx and efflux of
substrate, we can determine the voltage at which there is no net flux: the
reversal potential. Knowing this voltage allows straightforward thermodynamic
calculations that yield the coupling stoichiometry.
We tested this method on VcINDY, an electrogenic Naþ/Succinate2- sym-
porter, and MelB; an electrogenic Naþ/melibiose symporter, the latter has a
known coupling stoichiometry of 1:1. Our results firmly establish that VcINDY
has a 3:1 Naþ:succinate2- coupling stoichiometry and confirm the 1:1 coupling
stoichiometry of MelB.
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The LeuT Fold is characterized by a five transmembrane helix, inverted repeat
structure that has been observed in an increasing number of physiologically
